FDA staff said a proposed sleep drug from Merck was effective, but questioned the safety of the product's higher doses. Merck is seeking FDA approval of a drug called suvorexant to treat insomnia. The product will be reviewed Wednesday by an FDA advisory committee.
President Obama says you have to work twice as hard if you are black. Do you agree?
A new wave of private firms that cater to clients' every imaginable financial need are increasingly courting the merely wealthy. Here's what they offer.
To earn yields of 5% or more, investors are turning to more complex fare, such as high-yield corporate bonds, preferred stocks and real-estate investment trusts.
The stock market is expecting a massive new economic boom while the bond market sees the economy remaining in a funk. They can't both be right, but they can be wrong, writes Brett Arends.